Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

NEXT STORY
Yamana Gold Announces the Discovery of New Mineralized Zones at Wasamac and Provides an Update on Its Growth Projects
PREV STORY
Rubius Therapeutics to Host Virtual Preclinical Pipeline and Platform Technology Day on December 16, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Microbiology Analyzers Market By Type, By Product, By Specimen Type, By Disease Area, By Application, By End Users, By Region, Forecast & Opportunities, 2025

author_avatar
NASDAQ Market News

Immunocore strengthens IP position in the field of TCR-based therapeutics

PRESS RELEASE Immunocore strengthens IP position in the field of TCR-based therapeutics Notice of ...

author_avatar
NASDAQ Market News

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person

author_avatar
NASDAQ Market News